{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:33:29Z","timestamp":1781505209807,"version":"3.54.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142057","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T19:13:20Z","timestamp":1447182800000},"page":"e0142057","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients\u2019 Perceptions on Initiation, Reasons for Use, and Obtainment"],"prefix":"10.1371","volume":"10","author":[{"given":"Michael","family":"Liebrenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Buadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Caflisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.pa.19.040179.002531","article-title":"Molecular mechanisms in the receptor action of benzodiazepines","volume":"19","author":"E Costa","year":"1979","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1440-1681.1999.03151.x","article-title":"The 'ABC' of GABA receptors: a brief review","volume":"26","author":"M Chebib","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"Suppl 2","key":"ref3","first-page":"14","article-title":"The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety","volume":"66","author":"PP Roy-Byrne","year":"2005","journal-title":"The Journal of clinical psychiatry"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jad.2009.06.044","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management","volume":"117","author":"SB Patten","year":"2009","journal-title":"J Affect Disord"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0b013e3181c9bfe6","article-title":"Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome","volume":"30","author":"JW Lee","year":"2010","journal-title":"Journal of clinical psychopharmacology"},{"key":"ref6","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","author":"B Dell'osso","year":"2012","journal-title":"Eur Psychiatry"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00000542-198503000-00017","article-title":"Midazolam: pharmacology and uses","volume":"62","author":"JG Reves","year":"1985","journal-title":"Anesthesiology"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.110.002717","article-title":"Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology","volume":"63","author":"TI Saari","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","article-title":"Guidelines for the rational use of benzodiazepines. When and what to use","volume":"48","author":"H Ashton","year":"1994","journal-title":"Drugs"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0885066607307506","article-title":"Treatment of acute seizures and status epilepticus","volume":"22","author":"DJ Costello","year":"2007","journal-title":"Journal of intensive care medicine"},{"issue":"Suppl 2","key":"ref11","first-page":"4","article-title":"Attitudes toward benzodiazepines over the years","volume":"66","author":"JF Rosenbaum","year":"2005","journal-title":"The Journal of clinical psychiatry"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/YIC.0b013e328105e0f2","article-title":"Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies","volume":"22","author":"S Petitjean","year":"2007","journal-title":"International clinical psychopharmacology"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.1367","article-title":"Trends in psychotropic medication use among U.S. adults","volume":"16","author":"R Paulose-Ram","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5414\/CPP45030","article-title":"Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital","volume":"45","author":"M Nakao","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref15","article-title":"Benzodiazepine Harm: How Can It Be Reduced?","author":"M Lader","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"ref16","author":"L Baandrup","year":"2015"},{"issue":"Suppl 2","key":"ref17","first-page":"28","article-title":"Benzodiazepine use, abuse, and dependence","volume":"66","author":"CP O'Brien","year":"2005","journal-title":"The Journal of clinical psychiatry"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1983.03340060045024","article-title":"Long-term diazepam therapy and clinical outcome","volume":"250","author":"K Rickels","year":"1983","journal-title":"JAMA"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long-term therapeutic use of benzodiazepines: I. Effects of abrupt discontinuation","volume":"47","author":"K Rickels","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use","volume":"18","author":"MJ Barker","year":"2004","journal-title":"CNS Drugs"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00228-004-0808-2","article-title":"Patterns and correlates of benzodiazepine use in the French general population","volume":"60","author":"R Lagnaoui","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"issue":"1\u20132","key":"ref22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","article-title":"Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study","volume":"104","author":"SY Fang","year":"2009","journal-title":"Drug and alcohol dependence"},{"issue":"4","key":"ref23","first-page":"E208","article-title":"Use of benzodiazepines and related drugs in Manitoba: a population-based study","volume":"2","author":"S Alessi-Severini","year":"2014","journal-title":"Canadian Medical Association Open Access Journal"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"M Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"ref25","first-page":"7","article-title":"Benzodiazepine dependence: causalities and treatment options","volume":"77","author":"A Heberlein","year":"2009","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"H Ashton","year":"2005","journal-title":"Curr Opin Psychiatry"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.socscimed.2005.07.016","article-title":"Views of general practitioners and benzodiazepine users on benzodiazepines: a qualitative analysis","volume":"62","author":"JM Parr","year":"2006","journal-title":"Social science & medicine (1982)"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4088\/JCP.v65n0202","article-title":"Benzodiazepine prescription practices and substance abuse in persons with severe mental illness","volume":"65","author":"RE Clark","year":"2004","journal-title":"The Journal of clinical psychiatry"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/070674370605100706","article-title":"Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program","volume":"51","author":"RC Voshaar","year":"2006","journal-title":"Canadian journal of psychiatry"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1360-0443.2010.02933.x","article-title":"Agonist substitution\u2014a treatment alternative for high-dose benzodiazepine-dependent patients?","volume":"105","author":"M Liebrenz","year":"2010","journal-title":"Addiction (Abingdon, England)"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s001270050134","article-title":"Whom to ask for help in case of a mental disorder? Preferences of the lay public","volume":"34","author":"MC Angermeyer","year":"1999","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref32","first-page":"44","article-title":"Help-seeking by substance abusers: the role of harm reduction and behavioral-economic approaches to facilitate treatment entry and retention","volume":"165","author":"GA Marlatt","year":"1997","journal-title":"NIDA Res Monogr"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.addbeh.2006.01.002","article-title":"Social pressure, coercion, and client engagement at treatment entry: a self-determination theory perspective","volume":"31","author":"TC Wild","year":"2006","journal-title":"Addict Behav"},{"key":"ref34","article-title":"Internationale Klassifikation psychischer St\u00f6rungen: ICD-10, Kapitel V (F); Forschungskriterien","author":"H Dilling","year":"1994"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/clpt.1984.214","article-title":"Diazepam tapering in detoxification for high, \u00c4\u00eadose benzodiazepine abuse","volume":"36","author":"M Harrison","year":"1984","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"ref36","article-title":"High dose benzodiazepine dependence: Description of 29 patients treated with flumazenil infusion and stabilised with clonazepam","author":"G Quaglio","year":"2012","journal-title":"Psychiatry Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7517-7-22","article-title":"Do patients think cannabis causes schizophrenia?\u2014A qualitative study on the causal beliefs of cannabis using patients with schizophrenia","volume":"7","author":"A Buadze","year":"2010","journal-title":"Harm Reduct J"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-244X-14-141","article-title":"Adult attention-deficit\/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions","volume":"14","author":"M Liebrenz","year":"2014","journal-title":"BMC Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12888-015-0493-y","article-title":"High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal","volume":"15","author":"M Liebrenz","year":"2015","journal-title":"BMC Psychiatry"},{"key":"ref40","unstructured":"Mayring P, editor Qualitative content analysis. Forum qualitative sozialforschung\/forum: qualitative social research; 2000."},{"key":"ref41","first-page":"2","article-title":"Forum: Qualitative Social Research","author":"P Mayring","year":"2000","journal-title":"Qualitative Content Analysis"},{"key":"ref42","author":"P Mayring","year":"2014"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"A Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"issue":"334","key":"ref44","first-page":"194","article-title":"Long term use of benzodiazepines: the views of patients","volume":"40","author":"MB King","year":"1990","journal-title":"Br J Gen Pract"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-244X-11-90","article-title":"Benzodiazepine use and misuse among patients in a methadone program","volume":"11","author":"KW Chen","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"1\u20132","key":"ref46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jns.2009.08.029","article-title":"Essential tremor as a neuropsychiatric disorder","volume":"289","author":"ED Louis","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3899\/jrheum.120340","article-title":"The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review","volume":"90","author":"BL Richards","year":"2012","journal-title":"J Rheumatol Suppl"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0277-9536(94)00155-M","article-title":"Doctor-patient communication: a review of the literature","volume":"40","author":"LM Ong","year":"1995","journal-title":"Social science & medicine"},{"issue":"12","key":"ref49","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"64","author":"TA Zesiewicz","year":"2005","journal-title":"Neurology"},{"issue":"19","key":"ref50","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","article-title":"Evidence-based guideline update: Treatment of essential tremor Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"77","author":"TA Zesiewicz","year":"2011","journal-title":"Neurology"},{"issue":"7","key":"ref51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00002018-200326070-00003","article-title":"Benefits and risks of pharmacological treatments for essential tremor","volume":"26","author":"KE Lyons","year":"2003","journal-title":"Drug Saf"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/02791072.1975.10471526","article-title":"Diazepam Use by Patients in a Methadone Program How Serious A Problem?","volume":"7","author":"GE Woody","year":"1975","journal-title":"Journal of Psychoactive Drugs"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1360-0443.1996.9157238.x","article-title":"Drug treatment in Switzerland: harm reduction, decentralization and community response","volume":"91","author":"HK Klingemann","year":"1996","journal-title":"Addiction"},{"issue":"9525","key":"ref54","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(06)68804-1","article-title":"Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis","volume":"367","author":"C Nordt","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"ref55","first-page":"167","article-title":"Use of benzodiazepines in opiate addicted persons. Results of an inquiry in Basle","volume":"42","author":"D Ladewig","year":"1996","journal-title":"Sucht\u2014Zeitschrift f\u00fcr Wissenschaft und Praxis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7517-11-23","article-title":"Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis","volume":"11","author":"M Liebrenz","year":"2014","journal-title":"Harm Reduct J"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7517-3-20","article-title":"Expansion of opiate agonist treatment: an historical perspective","volume":"3","author":"RG Newman","year":"2006","journal-title":"Harm Reduct J"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"848","DOI":"10.7326\/0003-4819-155-12-201112200-00008","article-title":"Prescription medication abuse and illegitimate internet-based pharmacies","volume":"155","author":"AB Jena","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","article-title":"Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis","volume":"104","author":"JM Parr","year":"2009","journal-title":"Addiction (Abingdon, England)"},{"issue":"Suppl 2","key":"ref60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0022-3956(90)90045-R","article-title":"The benzodiazepines as drugs of abuse","volume":"24","author":"JO Cole","year":"1990","journal-title":"J Psychiatr Res"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10459-010-9260-5","article-title":"Improving the working relationship between doctors and pharmacists: is inter-professional education the answer?","volume":"17","author":"RM Gallagher","year":"2012","journal-title":"Advances in health sciences education"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1751-7176.2008.07434.x","article-title":"A cluster randomized trial to evaluate physician\/pharmacist collaboration to improve blood pressure control","volume":"10","author":"BL Carter","year":"2008","journal-title":"The Journal of Clinical Hypertension"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1345\/aph.1K612","article-title":"Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present","volume":"43","author":"S Benavides","year":"2009","journal-title":"Annals of Pharmacotherapy"},{"key":"ref64","article-title":"Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case report","author":"AGI Maremmani","year":"2013","journal-title":"Case reports in psychiatry"},{"issue":"7","key":"ref65","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.addbeh.2005.02.002","article-title":"On the importance of distinguishing shame from guilt: relations to problematic alcohol and drug use","volume":"30","author":"RL Dearing","year":"2005","journal-title":"Addict Behav"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: three decades of research. A comprehensive review","volume":"26","author":"E Vermeire","year":"2001","journal-title":"J Clin Pharm Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:00:46Z","timestamp":1540213246000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142057"}},"subtitle":[],"editor":[{"given":"Silvia","family":"Alessi-Severini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":66,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142057","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}